Conference Overview (XI Int Conf on AIDS)
AIDS Now A Manageable Disease - For Those Who Can Afford It
Published in AIDS Weekly, July 8th, 1996
The highlight of the XI International Conference on AIDS, to be held July 7-12, 1996, in Vancouver, Canada, will be the presentation of clinical trial results showing that the most potent of the new HIV protease inhibitors - when combined with zidovudine (AZT) and lamivudine (3TC) - can control HIV infection.
Tantalizing data from small but growing numbers of subjects suggest that as long as people with HIV infection can continue taking the three-drug combination, they can remain free of AIDS symptoms.
But for the 80 percent of people with HIV...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (1996-07-08)
More Articles from AIDS Weekly
- Conference Coverage (IBC Protease Inhibitors)
Agouron Protease Inhibitor Enters Triple Combination Trials - Conference Coverage (IBC Protease Inhibitors)
Ritonavir Combinations Shine in Early Studies - Conference Coverage (IBC Protease Inhibitors)
Roche Researcher: Saquinavir Safe, Active in 3TC/AZT Combination - AIDS Therapies
Two Combination Regimens Shown To Be Advantageous in AIDS Patients - AIDS Therapies (Lamivudine)
Renal Dysfunction Affects Pharmacokinetics - AIDS Therapies (Viramune)
Accelerated Approval Received for Viramune - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
